Search

everythinglearnresearchcommunity

for

Search:↓

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Hair loss doesn't affect COVID-19 severity.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

PCOS requires personalized treatment to improve life quality and reduce health risks.

Bariatric surgery improves health but often causes hair loss and vitamin deficiency.

The document concludes that Passiflora incarnata may help with anxiety, healthcare workers need mental support, common bacteria cause hospital UTIs, telehealth for heart failure needs research, kids' screen time has increased, pregnant teens are mostly okay with their body image, diagnosing post-surgery tuberculosis is hard, older and severely ill people are more likely to have long COVID symptoms, and psychiatrists should be part of pain management teams.

Passiflora incarnata may help with anxiety but has risks and drug interactions. There's a genetic link between Fragile X Syndrome and Autism Spectrum Disorder. 6.7% of urine cultures showed hospital-acquired urinary tract infections. Children used screens more during COVID-19, causing various health complaints. Autism Spectrum Disorder is often underdiagnosed in females. Dissociative disorders in childhood sexual abuse victims are more common in males. Most pregnant teenagers are not dissatisfied with their body image but worry about weight. Diagnosing tuberculosis after knee surgery is challenging due to non-specific symptoms. Post-COVID-19 syndrome is more common in older, severely affected patients. Psychiatrists should be part of pain management teams due to the psychological aspects of pain.

SLE and DM can coexist but are rare and need careful evaluation.

Exercise is crucial for managing polycystic ovary syndrome (PCOS) and improving overall health.

Post-COVID-19 patients are at risk for hair loss.

Acyzol could help treat conditions caused by zinc deficiency.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Caffeic acid helps protect rats from the harmful effects of acrylamide.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Levofloxacin may cause skin discoloration and hair loss as side effects.

Early treatment of acne is crucial to prevent scarring and psychological effects.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Ellis van Creveld syndrome, a rare genetic disorder, can cause unexpected abnormalities in various body organs, requiring thorough patient evaluations.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.

Four new substances—minoxidil, ferrimanitol ovalbumin, clarithromycin, and glucosamine-hydrochloride—can cause occupational asthma.

A woman with severe angioedema improved significantly after treatment with rituximab.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.